Published online 4 June 2001.
© The Rockefeller University Press, 0022-1007/2001/6/1333/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 11, June 4, 2001 1333-1340
A Critical Role for Lymphotoxin-β Receptor in the Development of Diabetes in Nonobese Diabetic Mice
Rachel Ettingera,
Sibyl H. Munsonb,
Cheng-Chi Chaod,
Mary Vadeboncoeurb,
Jon Tomab, and
Hugh O. McDevittb,c
a Basel Institute for Immunology, Basel CH-4005, Switzerland
b Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305
c Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
d Hyseq, Sunnyvale, California 94085
Dept. of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5124.650-723-9180650-725-4019
hughmcd{at}leland.stanford.edu
To assess the role of lymphotoxin-β receptor (LTβR) in diabetes pathogenesis, we expressed an LTβR–Fc fusion protein in nonobese diabetic (NOD) mice. The fusion protein was expressed in the embryo, reached high levels for the first 2 wk after birth, and then declined progressively with age. High expression of LTβR–Fc blocked diabetes development but not insulitis. After the decline in chimeric protein concentration, mice became diabetic with kinetics similar to the controls. Early expression of fusion protein resulted in disrupted splenic architecture. However, primary follicles and follicular dendritic cells, but not marginal zones, developed in aged mice. Hence, LTβR signaling is required for diabetes development and regulates follicular and marginal zone structures via qualitatively or quantitatively distinct mechanisms.
Key Words: autoimmune disease tumor necrosis factor LIGHT lymphoid development marginal zone
R. Ettinger and S. Munson contributed equally to this study.
© 2001 The Rockefeller University Press

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Grabner, R., Lotzer, K., Dopping, S., Hildner, M., Radke, D., Beer, M., Spanbroek, R., Lippert, B., Reardon, C. A., Getz, G. S., Fu, Y.-X., Hehlgans, T., Mebius, R. E., van der Wall, M., Kruspe, D., Englert, C., Lovas, A., Hu, D., Randolph, G. J., Weih, F., Habenicht, A. J.R.
(2009). Lymphotoxin {beta} receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. JEM
206: 233-248
[Abstract]
[Full Text]
-
Levisetti, M. G., Suri, A., Frederick, K., Unanue, E. R.
(2004). Absence of Lymph Nodes in NOD Mice Treated With Lymphotoxin-{beta} Receptor Immunoglobulin Protects From Diabetes. Diabetes
53: 3115-3119
[Abstract]
[Full Text]
-
Sung, H.-H., Juang, J.-H., Lin, Y.-C., Kuo, C.-H., Hung, J.-T., Chen, A., Chang, D.-M., Chang, S.-Y., Hsieh, S.-L., Sytwu, H.-K.
(2004). Transgenic Expression of Decoy Receptor 3 Protects Islets from Spontaneous and Chemical-induced Autoimmune Destruction in Nonobese Diabetic Mice. JEM
199: 1143-1151
[Abstract]
[Full Text]
-
Wu, Q., Fu, Y.-X., Sontheimer, R. D.
(2004). Blockade of Lymphotoxin Signaling Inhibits the Clinical Expression of Murine Graft-versus-Host Skin Disease. J. Immunol.
172: 1630-1636
[Abstract]
[Full Text]
-
Wu, Y., Han, B., Luo, H., Roduit, R., Salcedo, T. W., Moore, P. A., Zhang, J., Wu, J.
(2003). DcR3/TR6 Effectively Prevents Islet Primary Nonfunction After Transplantation. Diabetes
52: 2279-2286
[Abstract]
[Full Text]
-
Fava, R. A., Notidis, E., Hunt, J., Szanya, V., Ratcliffe, N., Ngam-ek, A., de Fougerolles, A. R., Sprague, A., Browning, J. L.
(2003). A Role for the Lymphotoxin/LIGHT Axis in the Pathogenesis of Murine Collagen-Induced Arthritis. J. Immunol.
171: 115-126
[Abstract]
[Full Text]
-
Kuai, J., Nickbarg, E., Wooters, J., Qiu, Y., Wang, J., Lin, L.-L.
(2003). Endogenous Association of TRAF2, TRAF3, cIAP1, and Smac with Lymphotoxin beta Receptor Reveals a Novel Mechanism of Apoptosis. J. Biol. Chem.
278: 14363-14369
[Abstract]
[Full Text]
-
Lu, T. T., Cyster, J. G.
(2002). Integrin-Mediated Long-Term B Cell Retention in the Splenic Marginal Zone. Science
297: 409-412
[Abstract]
[Full Text]
-
Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M., Cyster, J. G.
(2002). Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis. J. Immunol.
169: 424-433
[Abstract]
[Full Text]